The Hong Kong Securities and Futures Commission recently conducted an inquiry into the shareholding distribution of GUANZE MEDICAL (02427). The inquiry results revealed that as of May 13, 2026, 20 shareholders collectively held 894,236,943 shares of the company, representing 94.13% of its issued share capital. Consequently, only 55,763,057 shares, or 5.87% of the issued share capital, were held by other shareholders. The company's closing share price surged 967.9% from HK$0.53 on January 7, 2026, to HK$5.66 by May 13, 2026. As of May 26, 2026, the share price closed at HK$5.46, marking a 930.2% increase from the HK$0.53 closing price on January 7, 2026. The SFC cautioned that, given the high concentration of ownership among a limited number of shareholders, the company's share price could experience significant volatility even with small trading volumes. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares.